GULLEY, James;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; AS REPRESENTED BY THE SECRETARY;SCHLOM, Jeffrey;CAMPBELL, Christopher;THE UNITED STATES OF AMERICA;GILDERSLEEVE, Jeffrey;OYELARAN, Oyindasola; DEPARTMENT OF HEALTH AND HUMAN SERVICES
The invention provides a method for predicting the clinical response to a cancer vaccine in a patient having cancer, a method for determining the immune response to a cancer vaccine in a patient having cancer who has been administered a cancer vaccine, a method for determining the long-term survival in a patient having cancer, corresponding kits therefor, as well as methods of for improving the efficacy of a virus-based vaccine.La présente invention concerne une méthode permettant de prédire la réponse clinique à un vaccin anticancéreux chez un patient souffrant d'un cancer, une méthode permettant de déterminer la réponse immunitaire à un vaccin anticancéreux chez un patient souffrant d'un cancer et ayant reçu un vaccin anticancéreux, une méthode permettant de déterminer la survie à long terme d'un patient souffrant d'un cancer, des nécessaires à cet effet, ainsi que des méthodes visant à améliorer l'efficacité d'un vaccin à base virale.
